PanGen Biotech (222110.KQ) Stock Price

PanGen Biotech Price

CLOSED
4,990.00KRW-10.00 (-0.20 %)
Market closed

Over the last 12 years PanGen Biotech grew revenue by 12.7% annually, reaching 13.42 B KRW. For PanGen Biotech, the net margin of 15.3% is up versus -41.7% a few years ago. The stock trades about 15% above its 52-week low.

PanGen Biotech stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of PanGen Biotech over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how PanGen Biotech stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing PanGen Biotech's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

PanGen Biotech Stock Price History
DatePanGen Biotech Price
8/5/20264,990.00 KRW
8/4/20265,000.00 KRW
8/3/20264,980.00 KRW
7/31/20264,920.00 KRW
7/30/20264,910.00 KRW
7/29/20264,690.00 KRW
7/28/20264,780.00 KRW
7/27/20264,900.00 KRW
7/24/20264,800.00 KRW
7/23/20264,675.00 KRW
7/22/20264,600.00 KRW
7/21/20264,595.00 KRW
7/20/20264,580.00 KRW
7/16/20264,565.00 KRW
7/15/20264,560.00 KRW
7/14/20264,470.00 KRW
7/13/20264,465.00 KRW
7/10/20264,680.00 KRW
7/9/20264,580.00 KRW
7/8/20264,525.00 KRW
7/7/20264,610.00 KRW
7/6/20264,770.00 KRW
7/3/20264,820.00 KRW
7/2/20264,885.00 KRW
7/1/20264,895.00 KRW
6/30/20264,830.00 KRW
6/29/20264,545.00 KRW
6/26/20264,330.00 KRW
6/25/20264,345.00 KRW
6/24/20264,595.00 KRW
6/23/20264,540.00 KRW
6/22/20264,850.00 KRW
6/19/20264,885.00 KRW
6/18/20264,700.00 KRW
6/17/20264,815.00 KRW
6/16/20264,675.00 KRW
6/15/20264,795.00 KRW
6/12/20264,830.00 KRW
6/11/20264,600.00 KRW
6/10/20264,510.00 KRW
6/9/20264,710.00 KRW
6/8/20264,565.00 KRW
6/5/20265,030.00 KRW
6/4/20265,110.00 KRW
6/2/20264,905.00 KRW
6/1/20265,270.00 KRW
5/29/20265,070.00 KRW
5/28/20265,140.00 KRW
5/27/20265,230.00 KRW
5/26/20265,170.00 KRW
5/22/20265,390.00 KRW
5/21/20265,360.00 KRW
5/20/20265,680.00 KRW
5/19/20265,720.00 KRW
5/18/20266,250.00 KRW
5/15/20266,890.00 KRW
5/14/20266,170.00 KRW
5/13/20266,110.00 KRW
5/12/20266,500.00 KRW
5/11/20265,830.00 KRW
5/8/20266,200.00 KRW
5/7/20265,770.00 KRW
5/6/20265,780.00 KRW
5/4/20265,760.00 KRW
4/30/20265,950.00 KRW
4/29/20266,000.00 KRW
4/28/20266,010.00 KRW
4/27/20266,200.00 KRW
4/24/20265,990.00 KRW
4/23/20266,020.00 KRW
4/22/20266,080.00 KRW
4/21/20266,280.00 KRW
4/20/20266,780.00 KRW
4/17/20267,290.00 KRW
4/16/20267,340.00 KRW
4/15/20266,550.00 KRW
4/14/20265,750.00 KRW
4/13/20265,520.00 KRW
4/10/20265,100.00 KRW
4/9/20265,050.00 KRW
4/8/20265,130.00 KRW
4/7/20265,090.00 KRW
4/6/20265,300.00 KRW
4/3/20265,250.00 KRW
4/2/20264,960.00 KRW
4/1/20265,110.00 KRW
3/31/20265,150.00 KRW
3/30/20265,410.00 KRW
3/27/20265,500.00 KRW
3/26/20265,540.00 KRW
3/25/20265,360.00 KRW
3/24/20265,200.00 KRW
3/23/20264,890.00 KRW
3/20/20264,990.00 KRW
3/19/20264,950.00 KRW
3/18/20264,955.00 KRW
3/17/20264,990.00 KRW
3/16/20264,900.00 KRW
3/13/20264,890.00 KRW
3/12/20264,955.00 KRW
3/11/20265,000.00 KRW
3/10/20264,910.00 KRW
3/9/20264,955.00 KRW
3/6/20264,975.00 KRW
3/5/20265,100.00 KRW
2/26/20265,120.00 KRW
2/25/20265,300.00 KRW
2/24/20265,250.00 KRW
2/23/20265,220.00 KRW
2/20/20265,200.00 KRW
2/19/20265,300.00 KRW
2/13/20265,280.00 KRW
2/12/20265,260.00 KRW
2/11/20265,330.00 KRW
2/10/20265,350.00 KRW
2/9/20265,180.00 KRW
2/6/20265,140.00 KRW
2/5/20265,190.00 KRW
2/4/20265,250.00 KRW
2/3/20265,140.00 KRW
2/2/20265,100.00 KRW
1/30/20265,350.00 KRW
1/29/20265,580.00 KRW
1/28/20265,630.00 KRW
1/27/20265,530.00 KRW
1/26/20265,500.00 KRW
1/23/20265,360.00 KRW
1/22/20265,310.00 KRW
1/21/20265,500.00 KRW
1/20/20265,130.00 KRW
1/19/20265,050.00 KRW
1/16/20265,190.00 KRW
1/15/20265,270.00 KRW
1/14/20265,330.00 KRW
1/13/20265,400.00 KRW
1/12/20265,320.00 KRW
1/9/20265,410.00 KRW
1/8/20265,200.00 KRW
1/7/20265,130.00 KRW
1/6/20265,360.00 KRW
1/5/20265,350.00 KRW
1/2/20265,530.00 KRW
12/30/20255,600.00 KRW
12/29/20255,730.00 KRW
12/26/20255,650.00 KRW
12/24/20255,790.00 KRW
12/23/20255,850.00 KRW
12/22/20255,890.00 KRW
12/19/20255,890.00 KRW
12/18/20255,870.00 KRW
12/17/20255,870.00 KRW
12/16/20255,850.00 KRW
12/15/20255,780.00 KRW
12/12/20255,960.00 KRW
12/11/20255,970.00 KRW
12/10/20255,900.00 KRW
12/9/20256,050.00 KRW
12/8/20255,900.00 KRW
12/5/20256,070.00 KRW
12/4/20255,890.00 KRW
12/3/20255,840.00 KRW
12/2/20255,870.00 KRW
12/1/20255,720.00 KRW
11/28/20255,730.00 KRW
11/27/20255,550.00 KRW
11/26/20255,630.00 KRW
11/25/20255,580.00 KRW
11/24/20255,620.00 KRW
11/21/20255,560.00 KRW
11/20/20255,790.00 KRW
11/19/20255,720.00 KRW
11/18/20255,600.00 KRW
11/17/20255,760.00 KRW
11/14/20255,890.00 KRW
11/13/20255,910.00 KRW
11/12/20255,980.00 KRW
11/11/20255,930.00 KRW
11/10/20255,950.00 KRW
11/7/20255,980.00 KRW
11/6/20255,930.00 KRW
11/5/20255,940.00 KRW
11/4/20256,040.00 KRW
11/3/20255,640.00 KRW
10/31/20255,900.00 KRW
10/30/20255,860.00 KRW
10/29/20256,030.00 KRW
10/28/20256,100.00 KRW
10/27/20256,170.00 KRW
10/24/20256,120.00 KRW
10/23/20256,100.00 KRW
10/22/20256,130.00 KRW
10/21/20256,040.00 KRW
10/20/20256,140.00 KRW
10/17/20256,150.00 KRW
10/16/20256,340.00 KRW
10/15/20256,040.00 KRW
10/14/20255,760.00 KRW
10/13/20256,000.00 KRW
10/10/20256,060.00 KRW
10/2/20255,940.00 KRW
10/1/20255,940.00 KRW
9/30/20256,060.00 KRW
9/29/20256,120.00 KRW
9/26/20256,020.00 KRW
9/25/20256,080.00 KRW
9/24/20256,060.00 KRW
9/23/20256,300.00 KRW
9/22/20256,120.00 KRW
9/19/20256,040.00 KRW
9/18/20255,990.00 KRW
9/17/20255,980.00 KRW
9/16/20256,180.00 KRW
9/15/20256,240.00 KRW
9/12/20256,240.00 KRW
9/11/20256,290.00 KRW
9/10/20256,270.00 KRW
9/9/20256,200.00 KRW
9/8/20256,160.00 KRW
9/5/20256,020.00 KRW
9/4/20256,020.00 KRW
9/3/20256,080.00 KRW
9/2/20256,080.00 KRW
9/1/20255,970.00 KRW
8/29/20256,050.00 KRW
8/28/20255,980.00 KRW
8/27/20256,040.00 KRW
8/26/20255,950.00 KRW
8/25/20255,950.00 KRW
8/22/20255,980.00 KRW
8/21/20255,940.00 KRW
8/20/20255,710.00 KRW
8/19/20255,730.00 KRW
8/18/20255,810.00 KRW
8/14/20256,070.00 KRW
8/13/20255,970.00 KRW
8/12/20256,060.00 KRW
8/11/20255,960.00 KRW
8/8/20256,220.00 KRW
Access this data via the Eulerpool API
Get Free API Key

PanGen Biotech Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
5.68 B KRW
-3.04 B KRW
-4.63 B KRW
Jan 1, 2019
2.88 B KRW
-8.57 B KRW
-8.94 B KRW
Jan 1, 2020
6.19 B KRW
-3.70 B KRW
-4.36 B KRW
Jan 1, 2021
7.94 B KRW
-3.29 B KRW
-3.31 B KRW
Jan 1, 2022
6.50 B KRW
-4.59 B KRW
-4.49 B KRW
Jan 1, 2023
7.32 B KRW
-4.26 B KRW
-4.49 B KRW
Jan 1, 2024
14.67 B KRW
1.05 B KRW
943.69 M KRW
Jan 1, 2025
13.42 B KRW
1.51 B KRW
2.05 B KRW

PanGen Biotech Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 7, 2026, 10:08 AM
 
REVENUEB KRW
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB KRW
EBITB KRW
EBIT MARGIN%
NET INCOMEB KRW
NET INCOME GROWTH%
SHARESM
2013201420152016201720182019202020212022202320242025
3.213.403.731.462.375.682.886.197.946.507.3214.6713.42
–5.859.71-60.8362.35139.42-49.27114.8928.17-18.0812.54100.57-8.56
14.73-0.5315.58-153.11-62.149.10-72.7947.5025.9934.8235.3145.1144.53
0.47-0.020.58-2.24-1.470.52-2.102.942.062.262.586.625.97
-0.52-2.02-2.02-7.27-5.15-3.04-8.57-3.70-3.29-4.59-4.261.051.51
-16.16-59.41-54.21-497.60-217.28-53.58-297.36-59.76-41.44-70.62-58.267.1311.23
-1.37-2.12-2.64-5.13-7.02-4.63-8.94-4.36-3.31-4.49-4.490.942.05
–55.0824.3994.3536.88-34.0093.02-51.27-24.0035.74-0.11-121.01117.39
2.109.649.649.649.629.649.649.649.649.649.649.649.64
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales PanGen Biotech generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue PanGen Biotech retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare PanGen Biotech's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares PanGen Biotech has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against PanGen Biotech's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

PanGen Biotech stock margins

The PanGen Biotech margin analysis displays the gross margin, EBIT margin, as well as the profit margin of PanGen Biotech. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for PanGen Biotech.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
9.11 %
-53.59 %
-81.52 %
Jan 1, 2019
-72.79 %
-297.36 %
-310.19 %
Jan 1, 2020
47.50 %
-59.77 %
-70.36 %
Jan 1, 2021
25.99 %
-41.44 %
-41.71 %
Jan 1, 2022
34.81 %
-70.62 %
-69.13 %
Jan 1, 2023
35.31 %
-58.27 %
-61.36 %
Jan 1, 2024
45.11 %
7.13 %
6.43 %
Jan 1, 2025
44.53 %
11.23 %
15.28 %

PanGen Biotech Stock Revenue, EBIT, Earnings per Share

The PanGen Biotech earnings per share therefore indicates how much revenue PanGen Biotech has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
589.05 KRW
-315.66 KRW
-480.21 KRW
Jan 1, 2019
298.84 KRW
-888.63 KRW
-926.96 KRW
Jan 1, 2020
0.00 KRW
0.00 KRW
0.00 KRW
Jan 1, 2021
0.00 KRW
0.00 KRW
0.00 KRW
Jan 1, 2022
0.00 KRW
0.00 KRW
0.00 KRW
Jan 1, 2023
0.00 KRW
0.00 KRW
0.00 KRW
Jan 1, 2024
0.00 KRW
0.00 KRW
0.00 KRW
Jan 1, 2025
0.00 KRW
0.00 KRW
0.00 KRW

PanGen Biotech business model & stock analysis

PanGen Biotech Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

PanGen Biotech historical P/E ratio, EBIT multiple, and P/S ratio

PanGen Biotech annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

PanGen Biotech shares outstanding

The number of shares of PanGen Biotech was 9.64 M in 2025. This indicates how many shares PanGen Biotech is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
9.64 M Stocks
Jan 1, 2019
9.64 M Stocks
Jan 1, 2020
9.64 M Stocks
Jan 1, 2021
9.64 M Stocks
Jan 1, 2022
9.64 M Stocks
Jan 1, 2023
9.64 M Stocks
Jan 1, 2024
9.64 M Stocks
Jan 1, 2025
9.64 M Stocks
Price targets and forecasts for PanGen Biotech are not yet available.

PanGen Biotech shareholder structure

% Name
34.81942%
Huons Co.,Ltd.
Huons Co.,Ltd.
7.26608%
Hwail Pharmaceutical Co., Ltd.
Hwail Pharmaceutical Co., Ltd.
7.04970%
Chemical Company of Malaysia Bhd
Chemical Company of Malaysia Bhd
3.49666%
Yun (Jae Seung)
Yun (Jae Seung)
1.24512%
Yun (Seong Tae)
Yun (Seong Tae)
0.03934%
Lee (Gyu Yeon)
Lee (Gyu Yeon)

PanGen Biotech Executives and Management Board

15 members · avg. age 55

Management

JY

Mr. Jae Seung Yoon (63)

President, Chief Executive Officer · since 2024

–
TB

Tae Ho Byun (64)

Chief Operating Officer, Vice President

–
SA

Sang Guk Ahn (68)

Internal Auditor

–
HK

Hye Jin Kang (45)

Internal Auditor

–
SK

Mr. Sin Won Kang (50)

Internal Auditor

–
DK

Du Pyo Kim (65)

Internal Auditor

–

Board of Directors

JJ

Jeong Cheol Jung (54)

Director

–
GP

Gwang Hui Park (57)

Director

–
NP

No Jun Park (56)

Director

–
SS

Mr. Seung Su Shin (51)

Director

–
AW

Mr. Amir Jeffrey Wan (53)

Director

–
YY

Mr. Yin Sang Yoon (33)

Director

–

Frequently asked questions about PanGen Biotech

Converted at the current exchange rate, the PanGen Biotech share trades at 3.04 EUR (4,990.00 KRW).

No history available for PanGen Biotech.

The revenue cannot currently be calculated for PanGen Biotech.

The profit cannot currently be calculated for PanGen Biotech.

The P/E ratio cannot be calculated for PanGen Biotech at the moment.

The P/S cannot be calculated for PanGen Biotech currently.

The Eulerpool Quality Score for PanGen Biotech is 6/10.

The ISIN of PanGen Biotech is KR7222110009. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of PanGen Biotech is 222110.KQ. The ticker symbol is used to trade PanGen Biotech shares on the stock exchange.

PanGen Biotech paid dividends every year for the past 0 years.

PanGen Biotech is assigned to the 'Health' sector.

The dividends of PanGen Biotech are distributed in KRW.

All fundamentals and in-depth analysis of PanGen Biotech

Our stock analysis for PanGen Biotech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PanGen Biotech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

PanGen Biotech Stock
PanGen Biotech Revenue→
PanGen Biotech Stock
PanGen Biotech Net Income→
PanGen Biotech Stock
PanGen Biotech P/E→
PanGen Biotech Stock
PanGen Biotech P/S→
PanGen Biotech Stock
PanGen Biotech EBIT→
PanGen Biotech Stock
PanGen Biotech Dividend→
PanGen Biotech Stock
PanGen Biotech Directors Dealings→
PanGen Biotech Stock
PanGen Biotech Stocks→
PanGen Biotech Stock
PanGen Biotech Market capitalization→
PanGen Biotech Stock
PanGen Biotech Debt→
PanGen Biotech Stock
PanGen Biotech Liabilities→
PanGen Biotech Stock
PanGen Biotech Equity→
PanGen Biotech Stock
PanGen Biotech AAQS→
PanGen Biotech Stock
PanGen Biotech Employees→
PanGen Biotech Stock
PanGen Biotech ROE→
PanGen Biotech Stock
PanGen Biotech ROA→
PanGen Biotech Stock
PanGen Biotech ROCE→
PanGen Biotech Stock
PanGen Biotech News→
PanGen Biotech Stock
PanGen Biotech Analyst Price Targets→

Health Stocks

Panion & BF BiotechPangaea OncologyPar Drugs and ChemicalsPanchsheel OrganicsParadigm BiopharmaceuticalsPanacos PharmaceuticalsParadigm Medical IndustriesPanacea Life Sciences HoldingsParagon CarePanacea BiotecParallel IndustriesPalvella TherapeuticsAll Stocks A–Z →